ダウンロード数: 340

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
62_5_259.pdf831.63 kBAdobe PDF見る/開く
タイトル: Docetaxel 療法の効果を認めた原発性前立腺扁平上皮癌の1例
その他のタイトル: Primary Squamous Cell Carcinoma of the Prostate in which Docetaxel Therapy was Effective : A Case Report
著者: 森山, 浩之  KAKEN_name
梶原, 充  KAKEN_name
米原, 修治  KAKEN_name
著者名の別形: Moriyama, Hiroyuki
Kajiwara, Mitsuru
Yonehara, Shuji
キーワード: Prostate cancer
Squamous cell carcinoma
Docetaxel therapy
発行日: 31-May-2016
出版者: 泌尿器科紀要刊行会
誌名: 泌尿器科紀要
巻: 62
号: 5
開始ページ: 259
終了ページ: 264
抄録: The patient was a 73-year-old man who visited our hospital with asymptomatic gross hematuria. Cystoscopy revealed a bladder tumor in two places. Serum prostatic specific antigen was normal (2.535 ng/ml). Transurethral resection of bladder tumors was performed. In order to complete resection of bladder tumor, transurethral resection of right lobe of the prostate whitch had protruded into the bladder, was needed. Histology of the prostatic tissue revealed squamous cell carcinoma with no grandular and acinar structures. Serum SCC-antigen level was evaluated (6.2 ng/ml) after establishment of the diagnosis. Thoraco-abdominal computed tomography and 18-fluorodeoxyglucose positron emission tomography/ computed tomography (18F-FDG PET/CT) showed prostate cancer and multiple metastases in the lymph nodes, such as right external iliac, right common iliac, para-aortic and left supraclavicular region. The patient received external radiation therapy to the prostate and underwent systemic chemotherapy using docetaxel. After 2 courses of docetaxel therapy, multiple lymph nodes metastases were reduced and serum SCC-antigen level was normalized. Docetaxel therapy could not be continued because of a side effect of interstitial pneumonia.
著作権等: 許諾条件により本文は2017/06/01に公開
URI: http://hdl.handle.net/2433/215100
PubMed ID: 27320118
出現コレクション:Vol.62 No.5

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。